The Global Fund's Malaria Medicine Subsidy: A Nice Idea with Nasty Implications

Africa Fighting Malaria Policy Paper

22 Pages Posted: 22 Oct 2013

See all articles by Richard Tren

Richard Tren

Africa Fighting Malaria (US)

Roger Bate

American Enterprise Institute (AEI)

Kimberly Hess

Africa Fighting Malaria (US)

Thompson Ayodele

Initiative for Public Policy Analysis

Franklin Cudjoe

IMANI Center for Policy and Education

Date Written: September 8, 2011

Abstract

Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also seeks to drive out oral artemisinin monotherapies as their continued use threatens the entire class of drugs due to drug resistance.

Suggested Citation

Tren, Richard and Bate, Roger and Hess, Kimberly and Ayodele, Thompson and Cudjoe, Franklin, The Global Fund's Malaria Medicine Subsidy: A Nice Idea with Nasty Implications (September 8, 2011). Africa Fighting Malaria Policy Paper, Available at SSRN: https://ssrn.com/abstract=2342790 or http://dx.doi.org/10.2139/ssrn.2342790

Richard Tren

Africa Fighting Malaria (US) ( email )

Washington, DC
United States

Roger Bate (Contact Author)

American Enterprise Institute (AEI) ( email )

1150 17th Street, N.W.
Washington, DC 20036
United States

Kimberly Hess

Africa Fighting Malaria (US) ( email )

Washington, DC
United States

Thompson Ayodele

Initiative for Public Policy Analysis ( email )

2 Olufunmilayo Street (Ground Floor)
Off CMD Road
Ikosi, Lagos
Nigeria

Franklin Cudjoe

IMANI Center for Policy and Education ( email )

14 Yeboa Street Chantan
Achimota
Ghana

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
20
Abstract Views
267
PlumX Metrics